We envision a world where there is equity in experience and outcomes for all people diagnosed with cancer. There is no single action that will deliver this – it requires strategic investment, systemic and policy reform, and collective action.
That’s why we have proposed a united ‘Rare Cancer Moonshot’, an ambitious target that demands a concerted effort across government, healthcare, research, industry, and the community to radically accelerate progress so that by 2035:
- More than 90% of people diagnosed with cancer survive at least five years after diagnosis, regardless of rarity; and
- There is true equity of experience for everyone with cancer.
